Core and Group Health

Individual and small group health plans faced losses in 2025 as medical claims continued to climb, accelerating a shift toward alternative benefit models.

Program managers argue that some of the strength is due to lingering problems with enrollment fraud.

The state has accused the company of increasing its revenue by underpaying out-of-network providers.

Growth in retail prescription drug spending is expected to be fastest at an average of 5.7% per year.

Republican House members last week introduced a package of bills that would create a state hospital pricing board, limit hospital price increases, restrict health care consolidation and prohibit certain physician non-compete agreements.

Plan sponsors could spend $905 billion, or $9,627 per enrollee.